Morningside Healthcare has launched three new types of oral contraceptives adding to its range of products for women’s health.
The new oral contraceptives are:
Bimizza (Desogestrel 150 mcg + Ethinylestradiol 20 mcg)
Yacella (Ethinylestradiol 0.03 mg + Drospirenone 3 mg)
And the emergency contraceptive: Emerres (Levonorgestrel 1500 mcg)
More information for Healthcare Professionals is available here:
http://www.morningsidecontraceptives.com
For further sales information please contact customer services on 01509 217705 or email This email address is being protected from spambots. You need JavaScript enabled to view it.
For medical enquiries please contact medical information on +44 (0) 116 478 0322.
Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.